Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.63 Down 0.14(2.94%) 4:00PM EDT
|After Hours : 4.63 0.00 (0.00%) 5:04PM EDT
Prev Close:4.77
Open:4.70
Bid:4.63 x 2400
Ask:4.85 x 1000
1y Target Est:7.83
Beta:-2.36
Earnings Date:Jul 31 - Aug 1 (Est.)
Day's Range:4.61 - 4.75
52wk Range:4.05 - 7.97
Volume:4,473,832
Avg Vol (3m):5,355,060
Market Cap:1.02B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNADown 2.94%1.02B
GSKDown 0.21%116.18B
OREXDown 1.77%580.47M
RHHBYDown 1.36%246.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Jun-14) :-0.11
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback